Navigation Links
Completely novel action of insulin unveiled
Date:11/5/2008

und 10%.

Freddy Yip believes his study will create a strong foundation for future diabetes research. "We knew before that Myo1c was somehow involved in the regulation of glucose transport. My research indicates that Myo1c is a major target of insulin action and helps to accelerate the delivery of transporters to the membrane," he said.

"We think there may be blockages in the signal between insulin and myo1c in people who develop insulin resistance. If we're correct, it should be possible to target that pathway for development of new therapies."

Professor James sees the finding as a welcome milestone on a very long road of discovery. "While we're certainly not saying we've found a way to cure diabetes, we are saying we've found a pretty significant clue."


'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-434-071-326
Research Australia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. World first: researchers develop completely automated anesthesia system
2. Yo Mujer: Woman Escapes from Abusive Marriage in New Spanish-Language Novel
3. Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients
4. Preliminary Clinical Data Presented at the 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrate Superior Profile of S*BIOs Novel Anti-Cancer Drug SB939
5. Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications
6. NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting
7. Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center
8. Novel imaging approach may assist in predicting success of treatment for atrial fibrillation
9. NIH Awards a Phase I Small Business Innovative Research Grant on "Novel Laser Scanning Technology for Computed Radiography" to VIXAR and iCRco
10. Novel tuberculosis vaccine in Germany in clinical phase
11. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , ... July 07, 2015 , ... ... highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. Two ... Secretary of State looks more youthful than she has in some time and ...
(Date:7/7/2015)... NY (PRWEB) , ... July 07, 2015 , ... ... email newsletter and website that helps active people find the most fun activities to ... active lifestyle coverage for millennials. It also increases Greatist’s opportunity for events, e-commerce, and ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... group whose board is limited to permit holders. The Medical Cannabis Alliance of ... move the industry forward and are committed to making sure patients have access ...
(Date:7/7/2015)... ... ... end of June Pacific Prime Renewals team in Hong Kong announced that they were ... Manager, Danielle Cotton, aims to not only reduce but eventually eliminate the use of paper ... anything between 300 and 600 pieces of paper per month. Not to mention A4 sized ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation ... patient community using its IDF ePHR, an electronic personal health record powered by ... to easily track their health information, including symptoms, diagnoses, medications, infusions and other ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... 13, 2007 Schizophrenia is one of the most debilitating ... the most difficult to treat. Although numerous antipsychotic treatments ... patients experience only a partial relief of their symptoms and ... new study scheduled for publication in the December 15th issue ...
... to achieving financial ... success, ... that it was launching "The Power of Deliberate Creation," a,two-disc set and ... in a 7 step process. According to,inspirational author and financial success "guru" ...
... 13 Naviscan PET Systems(R), a,privately held company specializing ... Antonio Breast Cancer Symposium -- new clinical,data from a ... management., PEM Flex(TM) Solo II is a commercially ... small body parts such as the,breast and hand. Solo ...
... Phase II Study of Ofatumumab in Relapsed ... Diffuse Large B-Cell Lymphoma, COPENHAGEN, ... centers have been initiated and are,ready to enroll patients in a ... Large B-Cell Lymphoma (DLBCL) in,patients ineligible for or relapsed following a ...
... Dec. 13 ,GlaxoSmithKline (GSK) plc today presented an overview of its neuroscience,portfolio and ... York., ... Highlights, -- Innovative neuroscience pipeline ... schizophrenia, and multiple sclerosis (MS): ...
... U.S. Preventive Medicine(R),a company that is building ... the,United States and internationally ( http://www.USPreventiveMedicine.com ),announced ... intent with iHealth UK Ltd. to,jointly develop ... Kingdom.,iHealth brings together leading clinicians, advanced modalities, ...
Cached Medicine News:Health News:Effective new treatment for schizophrenia 2Health News:John Alexandrov Reveals 'the Secret' to Financial Success Via Launch of 'The Power of Deliberate Creation' Audio CDs 2Health News:John Alexandrov Reveals 'the Secret' to Financial Success Via Launch of 'The Power of Deliberate Creation' Audio CDs 3Health News:Naviscan's PEM Flex(TM) Scanner Shows Promising New Data in Breast Cancer Management 2Health News:Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma 2Health News:Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma 3Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 2Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 3Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 4Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 5Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 6Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 7Health News:GlaxoSmithKline Presents Innovative Neuroscience Pipeline 8Health News:U.S. Preventive Medicine to Expand into England with iHealth UK Ltd. 2Health News:U.S. Preventive Medicine to Expand into England with iHealth UK Ltd. 3
(Date:7/7/2015)... 7, 2015   Bionik Laboratories Corp. ... with a core focus in robotic exoskeleton technology ... "Company"), announced today that it has completed an ... consisting of its common stock and warrants for ... a private placement transaction.  This equity financing is ...
(Date:7/7/2015)... Oasmia Pharmaceutical AB, a ... human and veterinary oncology, today announced that it ... the United States , designed to generate ... therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... Paccal Vet-CA1 was previously distributed by ...
(Date:7/7/2015)...  Monopar Therapeutics LLC, an emerging biopharmaceutical company focusing ... and CEO, Chandler D. Robinson MD, MBA, ... Award. The British Council selected one recipient from each ... , and the United States ... who have leveraged their U.K. education in their subsequent ...
Breaking Medicine Technology:Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... pharmaceutical and medical device companies evolve, market research ... refining current ones to support intelligent planning and ... beginning to explore different types of technological advances ... external data collection and internal asset creation. ...
... 2012   CareFusion Corp. (NYSE: CFN ... that its board of directors authorized the repurchase of ... (Logo:  http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) "This ... potential and our commitment to increasing shareholder value," said ...
Cached Medicine Technology:Pharmaceutical Industry Leveraging New Tools to Overcome Challenges in Market Research 2CareFusion Announces $500 Million Share Repurchase Program 2CareFusion Announces $500 Million Share Repurchase Program 3
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: